Jeffrey K. Tobias

2012

In 2012, Jeffrey K. Tobias earned a total compensation of $4.1M as Executive Vice President, Research and Development and Chief Medical Officer at Jazz Pharmaceuticals.

Compensation breakdown

Bonus$125,000
Non-Equity Incentive Plan$250,000
Option Awards$1,619,569
Salary$422,023
Stock Awards$1,639,047
Other$4,527
Total$4,060,166

Tobias received $1.6M in stock awards, accounting for 40% of the total pay in 2012.

Tobias also received $125K in bonus, $250K in non-equity incentive plan, $1.6M in option awards, $422K in salary and $4.5K in other compensation.

Rankings

In 2012, Jeffrey K. Tobias' compensation ranked 1,613th out of 11,487 executives tracked by ExecPay. In other words, Tobias earned more than 86.0% of executives.

ClassificationRankingPercentile
All
1,613
out of 11,487
86th
Division
Manufacturing
577
out of 4,253
86th
Major group
Chemicals And Allied Products
127
out of 1,198
89th
Industry group
Drugs
68
out of 920
93rd
Industry
Pharmaceutical Preparations
57
out of 700
92nd
Source: SEC filing on June 12, 2013.

Tobias' colleagues

We found four more compensation records of executives who worked with Jeffrey K. Tobias at Jazz Pharmaceuticals in 2012.

2012

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2012

Suzanne Hooper

Jazz Pharmaceuticals

General Counsel

2012

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

2012

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

You may also like